Market Tracker

08/01 6:05pm ET

Nektar Therapeutics (NASDAQ:NKTR)

11.82
Data as of Aug 01
 +1.27 / +12.04%
Today’s Change
8.87
Today|||52-Week Range
15.34
+4.14%
Year-to-Date

Today’s Trading

Previous close10.55
Today’s open11.11
Day’s range10.68 - 11.83
Volume2,141,848
Average volume (3 months)1,135,414
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 08/01/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+55.10%
Earnings growth (next 5 years)+31.00%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.01+0.07%
DYAXDyax Corp-0.27-2.87%
ARIAARIAD Pharmaceutical...-0.15-2.60%
BRLIBio-Reference Labora...+0.37+1.18%
Data as of 4:00pm ET, 08/01/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.43
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts